Global Sepsis Diagnostics Market (2021 to 2028) – Increased Prevalence of Sepsis is Driving Growth – | Financial Buzz

Global Sepsis Diagnostics Market (2021 to 2028) – Increased Prevalence of Sepsis is Driving Growth –

The “Global Sepsis Diagnostics Market 2021-2028” report has been added to’s offering.

According to this report, the global sepsis diagnostics market is envisioned to surge at a CAGR of 8.18% through the projected period 2021-2028.

The rise in hospital-acquired infections among patients, paired with the increase in the prevalence of sepsis, are key factors supplementing the growth of the sepsis diagnostics market over the forecast period.

Additionally, the growing government initiatives for research activities related to sepsis are generating new opportunities for the studied market. However, the high cost of the instrument and reimbursement issues are likely to limit the global market’s growth.


The global sepsis diagnostics market comprises the Asia-Pacific, North America, Latin America, Europe, and the Middle East and Africa regions.

The Asia-Pacific is anticipated to observe the fastest growth rate in the sepsis diagnostics market over the considered period. The region’s lucrative growth can be attributed to the rapid economic development and advancement in the medical system in emerging economies like China and India. Further, the demand for sepsis diagnostics is expected to surge due to the high mortality rate associated with sepsis disease. Along with this, the rising awareness about sepsis diagnosis and treatment in the region’s nations is expected to counter the adverse effects of the disease. Hence, such factors are driving the growth of the sepsis diagnostics market across the APAC region.

Companies Mentioned

  • Abbott Laboratories
  • Becton Dickinson and Company (Cr Bard)
  • Biomerieux Sa
  • Bruker Corporation
  • Cytosorbents
  • Danaher Corporation
  • EKF Diagnostics
  • F Hoffmann-La Roche
  • Immunexpress Inc
  • Luminex Corporation
  • Response Biomedical Corporation
  • T2 Biosystems Inc
  • Thermo Fisher Scientific Inc

Key Topics Covered:

1. Global Sepsis Diagnostics Market – Summary

2. Industry Outlook

2.1. Impact of COVID-19 on Sepsis Diagnostics Market

2.2. Key Insights

2.3. Porter’s Five Forces Model

2.3.1. Threat of New Entrants

2.3.2. Threat of Substitute Products

2.3.3. Bargaining Power of Buyers

2.3.4. Bargaining Power of Suppliers

2.3.5. Competitive Rivalry

2.4. Market Attractiveness Index

2.5. Vendor Scorecard

2.6. Key Market Strategies

2.6.1. Contracts and Partnership

2.6.2. Business Expansion and Divestitures

2.6.3. Acquisitions & Mergers

2.6.4. New Product Launches

2.7. Market Drivers

2.7.1. Rise in Hospital-Acquired Infections Among Patients

2.7.2. Increased Prevalence of Sepsis

2.8. Market Restraints

2.8.1. High Cost Associated With the Instrument

2.8.2. Reimbursement Issues

2.9. Market Opportunities

2.9.1. Growth Opportunities in the Emerging Economies

2.9.2. Rising Government Initiatives for Research Activities Related to Sepsis

3. Global Sepsis Diagnostics Market – by Technology

3.1. Microbiology

3.2. Immunoassay

3.3. Molecular Diagnostics

3.4. Other Technologies

4. Global Sepsis Diagnostics Market – by Diagnostic Method

4.1. Conventional Diagnostics

4.2. Automated Diagnostics

5. Global Sepsis Diagnostics Market – by Product

5.1. Blood Culture Media

5.2. Assay Kits & Reagents

5.3. Instruments

6. Global Sepsis Diagnostics Market – by Pathogen

6.1. Gram – Positive and Gram – Negative Bacterial Sepsis

6.2. Fungal Sepsis

6.3. Other Pathogens

7. Global Sepsis Diagnostics Market – by Testing Type

7.1. Laboratory Testing

7.2. Point-Of-Care Testing

8. Global Sepsis Diagnostics Market – Regional Outlook

8.1. North America

8.2. Europe

8.3. Asia-Pacific

8.4. Latin America

8.5. Middle East and Africa

9. Competitive Landscape

9.1. Abbott Laboratories

9.2. Becton Dickinson and Company (Cr Bard)

9.3. Biomerieux Sa

9.4. Bruker Corporation

9.5. Cytosorbents

9.6. Danaher Corporation

9.7. EKF Diagnostics

9.8. F Hoffmann-La Roche

9.9. Immunexpress Inc

9.10. Luminex Corporation

9.11. Response Biomedical Corporation

9.12. T2 Biosystems Inc

9.13. Thermo Fisher Scientific Inc

10. Research Methodology & Scope

10.1. Research Scope & Deliverables

10.1.1. Objectives of Study

10.1.2. Scope of Study

10.2. Sources of Data

10.2.1. Primary Data Sources

10.2.2. Secondary Data Sources

10.3. Research Methodology

10.3.1. Evaluation of Proposed Market

10.3.2. Identification of Data Sources

10.3.3. Assessment of Market Determinants

10.3.4. Data Collection

10.3.5. Data Validation & Analysis

For more information about this report visit


Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900